» Authors » Alpana Shukla

Alpana Shukla

Explore the profile of Alpana Shukla including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 383
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lahooti A, Westerveld D, Johnson K, Aneke-Nash C, Baig M, Baig M, et al.
Gastrointest Endosc . 2024 Dec; PMID: 39694295
Background And Aims: Endoscopic sleeve gastroplasty (ESG) is a minimally invasive bariatric procedure of the gastric cavity to facilitate weight loss. We aimed to evaluate the long-term effects of ESG...
2.
Gaffey R, Takyi A, Shukla A
Expert Opin Investig Drugs . 2024 Jul; 33(8):757-773. PMID: 38984950
Introduction: One billion people live with obesity. The most promising medications for its treatment are incretin-based therapies, based on enteroendocrine peptides released in response to oral nutrients, specifically glucagon-like peptide-1...
3.
Singh H, Nair M, Kariya P, Bhatt S, Janardhanan D, Shanthi B, et al.
Indian Pediatr . 2024 Apr; 61(4):305-320. PMID: 38597099
Justification: The preconception period is the earliest window of opportunity to ensure optimal human development.  Pregnancy and childbirth outcomes can be improved by interventions offered to support the health and...
4.
Mehta A, Shah S, Dawod E, Hajifathalian K, Kumar R, Igel L, et al.
Am Surg . 2021 Aug; 89(4):707-713. PMID: 34384255
Background: We conducted this study to compare the weight loss outcome of intragastric balloons (IGBs) in conjunction with pharmacotherapy vs IGB and intensive lifestyle changes alone. Methods: This was a...
5.
Sharaiha R, Hajifathalian K, Kumar R, Saunders K, Mehta A, Ang B, et al.
Clin Gastroenterol Hepatol . 2020 Oct; 19(5):1051-1057.e2. PMID: 33011292
Background And Aims: The growing burden of obesity as a chronic disease necessitates a multifaceted approach to management. There has been an increase in the number of available endoscopic therapies...
6.
Hajifathalian K, Mehta A, Ang B, Skaf D, Shah S, Saumoy M, et al.
Gastrointest Endosc . 2020 Aug; 93(5):1110-1118. PMID: 32861753
Background And Aims: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the United States and is closely associated with obesity and insulin resistance...
7.
Rosenbaum M, Heaner M, Goldsmith R, Schulze P, Shukla A, Shen W, et al.
Obesity (Silver Spring) . 2018 Sep; 26(10):1576-1583. PMID: 30260099
Objective: The objective of this study is to determine whether resistance training is similarly effective in reducing skeletal muscle efficiency and increasing strength in weight-reduced and maximal weight subjects. Methods:...
8.
Novikov A, Afaneh C, Saumoy M, Parra V, Shukla A, Dakin G, et al.
J Gastrointest Surg . 2017 Nov; 22(2):267-273. PMID: 29110192
Background: Endoscopic sleeve gastroplasty (ESG) is a novel endobariatric procedure. Initial studies demonstrated an association of ESG with weight loss and improvement of obesity-related comorbidities. Our aim was to compare...
9.
Saumoy M, Schneider Y, Zhou X, Shukla A, Kahaleh M, Aronne L, et al.
Gastrointest Endosc . 2017 Aug; 87(2):442-447. PMID: 28843586
Background And Aims: Endoscopic sleeve gastroplasty (ESG) is a novel, incisionless technique for gastric volume reduction to promote weight loss. Our aim was to describe the learning curve for performing...
10.
Lopez-Nava G, Sharaiha R, Vargas E, Bazerbachi F, Manoel G, Bautista-Castano I, et al.
Obes Surg . 2017 Apr; 27(10):2649-2655. PMID: 28451929
Background: Endoscopic sleeve gastroplasty (ESG) is a technique for managing mild to moderately obese patients. We aimed to evaluate the long-term outcomes, reproducibility, and predictors of weight response in a...